Showing results (61-70 of 4,868) with videos related to

Sort By:
Pageof 487
Urologic Oncology|December 10, 2024
Integrated care among patients with kidney or urinary bladder cancer: An NCI patterns-of-care analysisKirsten Y Eom, Bhupinder Mann, Michael T Halpern
Urologic Oncology|December 13, 2024
Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapyRoberto Contieri, Francesco Claps, Rodolfo Hurle, et al.
Urologic Oncology|December 25, 2024
The role of neoadjuvant systemic therapy for high grade upper tract urothelial carcinoma: Results from the upper tract collaborative network (UCAN)Gianpaolo P Carpinito, Thomas Gerald, Patrick J Hensley, et al.
Urologic Oncology|December 14, 2024
Patient preferences for life expectancy cutoffs for aggressive treatment in clinically localized prostate cancerJohn R Heard, John M Masterson, Michael Luu, et al.
Urologic Oncology|November 16, 2024
The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal massesMichael Wang, Aaron Wilke, Samuel Goorman, et al.
Urologic Oncology|November 13, 2024
Innovative 3D method predicts surgery outcomes by calculating real contact surface of renal tumorPaolo Traverso, Alessandro Carfì, Alessandra Bulanti, et al.
Urologic Oncology|February 26, 2025
Characterization of metabolic and imaging profiles in the diagnosis of succinate dehydrogenase- related hereditary pheochromocytomas and paragangliomasJessica Y Hsueh, Neil Mendhiratta, Julie Solomon, et al.
Urologic Oncology|February 19, 2025
Impact of IRAES on the outcomes of pembrolizumab therapy in patients with MUC: A comprehensive analysis of severity and the type and number of affected organsIchiro Yonese, Yosuke Yasuda, Kosuke Takemura, et al.
Urologic Oncology|November 5, 2024
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meetingStephanie A Berg, Salvatore La Rosa, Tian Zhang, et al.
Urologic Oncology|November 16, 2025
Utilization of radical nephrectomy for patients with clinical stage T1 renal masses: Evaluation of opportunities for quality improvementAlice Semerjian, Emily Fisher, Amit Patel, et al.
Pageof 487